This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life | MicrobiomeTrials
← Back to trials NCT06026644
Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life Completed OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2022-06-29Est. Completion: 2024-02-15
Enrollment target: 170 participantsLocations Aou Di Bologna - Policlinico S. Orsola-malpighi - Uoc Ematologia, Bologna, Italy Asst Degli Spedali Civili Di Brescia - Ssvd Centro Trapianti Midollo Per Adulti - Cattedra Di Ematologia, Brescia, Italy AOU Careggi - SOD terapie cellulari e Medicina Trasfusionale, Florence, Italy Irccs Aou San Martino - Genova - Uo Ematologia E Trapianti, Genova, Italy Fondazione Irccs "Istituto Nazionale Tumori" - Milano - Sc Ematologia, Milan, Italy Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Ad Indirizzo Oncologico, Palermo, Italy Asl Pescara, Presidio Ospedaliero 'Spirito Santo' - Uoc Ematologia Clinica, Pescara, Italy Aou Pisana - Uo Ematologia Universitaria, Pisa, Italy Aou Policlinico Umberto I - Dipartimento Di Medicina Traslazionale - Sezione Ematologia, Roma, Italy Ististuto Clinico Humanitas - Rozzano - Uo Oncologia Medica Ed Ematologia, Rozzano, Italy Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Università Degli Studi Di Torino, Torino, Italy Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2, Torino, Italy Other microbiome trials you might be interested in Mantle Cell Lymphoma (MCL) Diffuse Large B-Cell Lymphoma (DLBCL) Follicular Lymphoma ( FL) Waldenström Macroglobulinemia (WM) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
BTK inhibitors and BCL-2 inhibitors have demonstrated significant clinical activity in mature B-cell malignancies, and c…
Multiple Locations Est. completion Jun 30, 2029
Diffuse Large B Cell Lymphoma Refractory Diffuse Large B Cell Lymphoma Relapsed
Aulss 8 Berica - Ospedale Di Vicenza - Uoc Ematologia, Vicenza, Italy Epstein-Barr Virus (EBV) Infection
This is a Phase Ib in adult patients with relapsed or refractory EBV-positive DLBCL using daily oral dosing of VK-2019 i…
Lexington, United States Est. completion Oct 1, 2028